Status:
COMPLETED
Pneumonia Vaccine Education Intervention Study
Lead Sponsor:
Geisinger Clinic
Conditions:
Pneumonia, Pneumococcal
Vaccine
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
The goal of this interventional clinical trial is to investigate the impact of medicine and pharmacy-led education on patient acceptance rates of Prevnar 20 pneumonia vaccination in patients eligible ...
Detailed Description
BACKGROUND Pneumococcal disease, a significant cause of morbidity and mortality in at-risk adult populations, remains substantially under-vaccinated despite the availability of an effective vaccine a...
Eligibility Criteria
Inclusion
- Patients admitted to inpatient Family Medicine service with Type I and II Diabetes.
- Patients who have not been previously vaccinated against pneumonia.
- Patients meeting specific eligibility for Prevnar 20 vaccine: Over age of 65 OR have been diagnosed with any of the following: diabetes, chronic obstructive pulmonary disease, or asthma.
Exclusion
- Patients that already received pneumonia vaccination in care history.
- Patients with pneumonia inpatient diagnosis at time of recruitment.
- Patients with any active infections.
- Patients who are in an immunosuppressed status.
- Patients allergic to any components of the vaccine.
Key Trial Info
Start Date :
May 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 26 2025
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT06136832
Start Date
May 6 2024
End Date
January 26 2025
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger South Wilkes-Barre
Wilkes-Barre, Pennsylvania, United States, 18702